DIAXONHIT and the University Hospitals of Strasbourg launch the Central European Laboratory dedicated to AlloMap(R) testing
May 25, 2016 12:31 ET
|
Diaxonhit
DIAXONHIT - Heart transplant monitoring
AlloMap®, the new molecular test to monitor heart transplant patients
PARIS and STRASBOURG, France, May 25, 2016 (GLOBE NEWSWIRE) -- DIAXONHIT...
Diaxonhit: 2015 Consolidated Income: EU29.5 M
January 27, 2016 03:41 ET
|
Diaxonhit
PARIS, Jan. 27, 2016 (GLOBE NEWSWIRE) -- DIAXONHIT (Alternext : ALEHT, FR0004054427), a French leader in specialty in vitro diagnostics for transplantation, infectious diseases and cancer, announces...
Diaxonhit : Clinical utility and performance of the AlloMap(r) heart transplant test confirmed in European study
June 03, 2015 11:56 ET
|
Diaxonhit
DIAXONHIT - AlloMap® Heart Transplant Surveillance Solution
Clinical utility and performance of the AlloMap® heart transplant test confirmed in European study
CARGO II clinical...
DIAXONHIT announces the CE marking of the BJI InoPlex(r) test and its commercial launch
January 14, 2015 01:36 ET
|
Diaxonhit
DIAXONHIT - Prosthetic joint infections test
DIAXONHIT announces the CE marking of the BJI InoPlex® test
and its commercial launch
The first and only non-invasive serological test...
DIAXONHIT announces that Strasbourg University Hospital will become its European Central Laboratory for processing the CareDx(r) AlloMap(r) heart transplant tests
January 12, 2015 01:37 ET
|
Diaxonhit
DIAXONHIT - Heart transplant test
DIAXONHIT announces that Strasbourg University Hospital will become its European Central Laboratory for processing the CareDx® AlloMap® heart...
Diaxonhit announces the good performance of BJI InoPlex(r) its test for the diagnosis of prosthetic infections at the 34th RICAI meeting
December 01, 2014 06:06 ET
|
Diaxonhit
The first non-invasive, quick and objective test for identification of antibacterial antibodies from a simple blood sample
A test targeting different families of bacteria, particularly...
DIAXONHIT - BJI InoPlex(TM) test: Completion of patients enrollment in the final validation study of the first diagnostic test for prosthetic bone and joint infections
September 24, 2014 12:45 ET
|
Diaxonhit
Final performance and CE marking expected before the end of 2014
Commercial launch early 2015, strengthening Diaxonhit's diagnostic product offering in infectious diseases
PARIS,...
Diaxonhit and CareDx Present New AlloMap(R) Clinical Abstracts at the Annual ISHLT Conference in San Diego
May 05, 2014 11:52 ET
|
Diaxonhit
US - Europe AlloMap Symposium
Four new clinical abstracts highlighting the clinical utility of AlloMap
Paris, May 5, 2014 (GLOBE NEWSWIRE) -- Diaxonhit (Alternext : ALEHT) sponsored and...
DIAXONHIT: 2013 consolidated income increases to EU30.5 million, 11% growth of diagnostic product sales
January 28, 2014 12:23 ET
|
Diaxonhit
2013 consolidated income increases to €30.5 million
11% growth of in vitro diagnostic product sales
PARIS, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Diaxonhit, the leading French provider of...